Fruit Lowers Type 2 Diabetes Risk + Moderna’s Manufacturing Partnerships

Fruit Lowers Type 2 Diabetes Risk + Moderna’s Manufacturing Partnerships

In this episode, Ayesha talks about new research from Australia showing that eating fruit could lower the risk of developing type 2 diabetes. Researchers at the Edith Cowan University’s (ECU) Institute for Nutrition Research in Perth, Australia found that consuming at least two servings of fruit a day was linked to an over one third lower odds of developing the disease. The same benefit was not seen for drinking fruit juice. This isn’t the first study that has found a link between fruit intake and a lower risk of type 2 diabetes. Fruit is loaded with fiber, vitamins, minerals and antioxidants that likely work together to offer significant health benefits.

The group also discussed Moderna’s COVID-19 vaccine manufacturing partnerships, including its latest deal with South Korea’s Samsung Biologics. As Moderna’s first authorized product, the company doesn’t have the manufacturing capacities to produce enough doses of its COVID-19 mRNA vaccine to meet global demands. Given this, CDMOs like Lonza and Catalent partnered early on with Moderna to manufacture millions of doses of the vaccine. And now with more manufacturing deals, Moderna has ambitiously pledged to produce up to 1 billion doses of its vaccine this year, and 3 billion by 2022.

Listen on Apple Podcasts

Read the full articles here:

Can Fruit Lower the Risk of Type 2 Diabetes?

Moderna Strikes Manufacturing Deal with Samsung Biologics for COVID-19 Vaccine Production

The weekly podcast is available for streaming every Wednesday on SpotifyApple Music and wherever you stream your podcasts.

Subscribe to the Xtalks Life Science Podcast to never miss a new episode.